Adaptimmune Therapeutics plc (NASDAQ:ADAP) Sees Large Decline in Short Interest

Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) saw a significant decrease in short interest in December. As of December 15th, there was short interest totalling 5,060,000 shares, a decrease of 24.7% from the November 30th total of 6,720,000 shares. Based on an average trading volume of 1,840,000 shares, the days-to-cover ratio is presently 2.8 […]

Leave a Reply

Your email address will not be published.

Previous post Middle East latest: Ukraine’s foreign chief pledges support for a new Syria on a trip to Damascus
Next post WaFd, Inc (NASDAQ:WAFD) Short Interest Up 26.8% in December